Effect of SGLT2 inhibitor on lactic acid,ketone bodies,glucagon in type 2 diabetes mellitus patients.
Not Applicable
Recruiting
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000015759
- Lead Sponsor
- Department of Endoclinology, Gifu University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Type 1 diabetes mellitus. 2) having diabetic ketoacidosis, nonketotic hyperosmolar coma, infection. 3) being pregnant or possibly pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of serum lactic acid, ketone bodies,CPR,and glucagon value comparing with baseline.
- Secondary Outcome Measures
Name Time Method Comparing with baseline change of urinalysis (sodium, potassium, glucose,osmotic pressure),uric acid,PRA,PAC,ACTH,cortisol,AVP,osmotic pressure.